'A new venture, led by the founder of a biotech group that was sold to Sanofi for up to $1.45bn in 2021, has won £48mn in funding for research into cancer treatments using machine learning and genetically engineered mouse technology.'

https://www.ft.com/content/73c41613-5fc7-499b-9858-2eeb456014bb